High glucose suppresses embryonic stem cell differentiation into cardiomyocytes
Open Access
- 9 December 2016
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 7 (1) , 1-13
Abstract
Background: Babies born to mothers with pregestational diabetes have a high risk for congenital heart defects (CHD). Embryonic stem cells (ESCs) are excellent in vitro models for studying the effect of high glucose on cardiac lineage specification because ESCs can be differentiated into cardiomyocytes. ESC maintenance and differentiation are currently performed under high glucose conditions, whose adverse effects have never been clarified.Method: We investigated the effect of high glucose on cardiomyocyte differentiation from a well-characterized ESC line, E14, derived from mouse blastocysts. E14 cells maintained under high glucose (25 mM) failed to generate any beating cardiomyocytes using the hanging-drop embryonic body method. We created a glucose-responsive E14 cell line (GR-E14) through a graduated low glucose adaptation. The expression of stem cell markers was similar in the parent E14 cells and the GR-E14 cells.Results: Glucose transporter 2 gene was increased in GR-E14 cells. When GR-E14 cells were differentiated into cardiomyocytes under low (5 mM) or high (25 mM) glucose conditions, high glucose significantly delayed the appearance and reduced the number of TNNT2 (Troponin T Type 2)-positive contracting cardiomyocytes. High glucose suppressed the expression of precardiac mesoderm markers, cardiac transcription factors, mature cardiomyocyte markers, and potassium channel proteins. High glucose impaired the functionality of ESC-derived cardiomyocytes by suppressing the frequencies of Ca2+wave and contraction.Conclusions: Our findings suggest that high glucose inhibits ESC cardiogenesis by suppressing key developmental genes essential for the cardiac program.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK083243, R01DK101972, R01DK103024)
- National Heart, Lung, and Blood Institute (R01 HL131737)
This publication has 62 references indexed in Scilit:
- DMH1, a Novel BMP Small Molecule Inhibitor, Increases Cardiomyocyte Progenitors and Promotes Cardiac Differentiation in Mouse Embryonic Stem CellsPLOS ONE, 2012
- Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to CardiomyocytesCirculation Research, 2012
- Frontiers in research on maternal diabetes-induced neural tube defects: Past, present and futureWorld Journal of Diabetes, 2012
- Improving murine embryonic stem cell differentiation into cardiomyocytes with neuregulin-1: differential expression of microRNAAmerican Journal of Physiology-Cell Physiology, 2011
- Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiationJournal of Cell Biology, 2011
- Minimization of exogenous signals in ES cell culture induces rostral hypothalamic differentiationProceedings of the National Academy of Sciences, 2008
- Hyperpolarization‐activated cyclic nucleotide‐modulated ‘HCN’ channels confer regular and faster rhythmicity to beating mouse embryonic stem cellsThe Journal of Physiology, 2008
- Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitroJournal of Neuroscience Methods, 2008
- Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular developmentCardiovascular Diabetology, 2007
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998